| Literature DB >> 12071114 |
R E Gianneechini1, C Concha, A Franklin.
Abstract
A total of 522 strains belonging to streptococci, enterococci and staphylococci isolated from sub-clinical and clinical cases of bovine mastitis from the west littoral region of Uruguay were analysed for their susceptibility to several antimicrobial agents. The susceptibility patterns were studied by agar disk diffusion methods (ADDM) and broth micro-dilution to determine the minimum inhibitory concentration (MIC). The concentration that inhibits 90% (MIC90) of the analysed strains reported in micrograms per millilitre, for Staphylococcus aureus were > 8, 8, < or = 0.5, < or = 4, < or = 1, < or = 0.5, > 64, < or = 0.25, 0.5, < or = 1 and < or = 1 to penicillin, ampicillin, oxacillin, cephalotin, gentamicin, erythromycin, oxitetracycline, enrofloxacin, trimethoprim/sulfamethoxazole, neomycin, and clindamycin, respectively. Coagulase-negative staphylococci (CNS) had different values for penicillin (4) and ampicillin (2), while the other antimicrobial agents had the same MIC90 values as reported for S. aureus. The MIC90 values for streptococci were 0.12, 0.25, < or = 4, 16, < or = 0.25, 0.5, 0.25 for penicillin, ampicillin, cephalotin, gentamicin, erythromycin, oxytetracycline and trimethoprim-sulfamethoxazole, whereas MIC90 for enterococci were 4, 4, 4, < or = 0.5, 2, > 8 for penicillin, ampicillin, gentamicin, erythromycin, oxytetracycline and trimethoprim-sulfamethoxazole, respectively. Of 336 strains of S. aureus, 160 (47.6%) were resistant to penicillin. For 41 CNS strains, 10 (27%) presented penicillin-resistance. All the streptococcal strains were susceptible to penicillin, while 3 (7%) of the 43 enteroccocal strains were resistant. Non significant statistical differences were found between the results obtained by ADDM and broth micro-dilution for classifying bacterial isolates as susceptible or resistant according to the National Committee of Clinical Laboratory Standards.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12071114 PMCID: PMC1764182 DOI: 10.1186/1751-0147-43-31
Source DB: PubMed Journal: Acta Vet Scand ISSN: 0044-605X Impact factor: 1.695
In vitro susceptibility of 336 strains of Staphylococcus aureus obtained from clinical and sub-clinical bovine mastitis cases from the West Littoral Region of Uruguay.
| MIC1 (μg/ml) | % Resistance | |||||
|---|---|---|---|---|---|---|
| Antimicrobial Agent | MIC502 | MIC903 | Range | Breakpoint | VETMIC | Agar disk diffusion test |
| Penicillin | 0.5 | > 8 | 0.12–> 8 | ≥ 0.25 | 47.6 | 46.1 5 |
| Ampicillin | 0.5 | 8 | ≤ 0.12–> 16 | ≤ 0.5 | 46.7 | 46.6 5 |
| Oxacillin | ≤ 0.5 | ≤ 0.5 | ≤ 0.5–1 | ≥ 4 | 0.0 | 2.0 5 6 |
| Cephalotin | ≤ 4 | ≤ 4 | ≤ 4 | ≤ 32 | 0.0 | 0.0 |
| Gentamicin | ≤ 1 | ≤ 1 | ≤ 1–4 | ≥ 16 | 0.0 | 0.0 |
| Erythromycin | ≤ 0.5 | ≤ 0.5 | ≤ 0.5–> 4 | ≥ 8 | 3.0 | 2.6 5 |
| Oxitetracycline | 2 | > 64 | ≤ 0.25–> 64 | ≥ 16 | 13.4 | 14.0 5 7 |
| Enrofloxacin | ≤ 0.25 | ≤ 0.25 | ≤ 0.25–0.5 | ≥ 2 | 0.0 | 0.0 |
| Neomycin | ≤ 1 | ≤ 1 | ≤ 1–64 | ≥ 64 | 0.6 | 0.9 5 |
| Clindamycin | ≤ 1 | ≤ 1 | ≤ 1 | ≥ 4 | 0.0 | ....4.... |
| Amoxicillin/Clavulanic acid | ....4.... | ....4.... | ....4.... | ....4.... | ....4.... | 0.0 |
| Trimethoprim/ | ||||||
| Sulfamethox. | 0.25 | 0.5 | < 0.06–8 | ≥ 4 | 0.3 | 0.0 5 |
1 Minimum inhibitory concentration. 2 Lowest concentration inhibiting 50% of the isolated tested.
3 Lowest concentration inhibiting 90% of the isolated tested. 4 Test not performed.
5 No significant differences between methods. 6 All strains were sensitive at the confirmation test.
7 Tetracycline disk were used to perform agar disks diffusion.
In vitro susceptibility of 41 strains of Coagulase Negative Staphylococcus obtained from clinical and sub-clinical bovine mastitis cases from the West Littoral Region of Uruguay.
| MIC1(μg/ml) | % Resistance | |||||
|---|---|---|---|---|---|---|
| Antimicrobial Agent | MIC502 | MIC903 | Range | Breakpoint | VETMIC | Agar disk diffusion test |
| Penicillin | 0.5 | > 4 | 0.12–> 8 | ≥ 0.25 | 27.0 | 22.0 5 |
| Ampicillin | 0.5 | 2 | ≤ 0.12–> 16 | ≤ 0.5 | 24.4 | 22.0 5 |
| Oxacillin | ≤ 0.5 | ≤ 0.5 | ≤ 0.5–1 | ≥ 4 | 0.0 | 0.0 |
| Cephalotin | ≤ 4 | ≤ 4 | ≤ 4 | ≤ 32 | 0.0 | 0.0 |
| Gentamicin | ≤ 1 | ≤ 1 | ≤ 1–4 | ≥ 16 | 0.0 | 0.0 |
| Erythromycin | ≤ 0.5 | ≤ 0.5 | ≤ 0.5 | ≥ 8 | 0.0 | 0.0 |
| Oxitetracycline | 2 | > 64 | ≤ 0.25–> 64 | ≥ 16 | 13.9 | 13.9 6 |
| Enrofloxacin | ≤ 0.25 | ≤ 0.25 | ≤ 0.25–0.5 | ≥ 2 | 0.0 | 0.0 |
| Neomycin | ≤ 1 | ≤ 1 | ≤ 1–64 | ≥ 64 | 2.0 | 2.0 |
| Clindamycin | ≤ 1 | ≤ 1 | ≤ 1 | ≥ 4 | 0.0 | ....4.... |
| Amoxicillin/Clavulanic acid | ....4.... | ....4.... | ....4.... | ....4.... | ....4.... | 0.0 |
| Trimethoprim/Sulfamethox. | 0.25 | 0.5 | < 0.06–8 | ≥ 4 | 7.3 | 0.0 5 |
1 Minimum inhibitory concentration. 2 Lowest concentration inhibiting 50% of the isolated tested.
3 Lowest concentration inhibiting 90% of the isolated tested. 4 Test not performed.
5. No significant differences between methods. 7 Tetracycline disk were used to perform agar disks diffusion.
In vitro susceptibility of 60 strains of Streptococcus agalactiae obtained from clinical and sub-clinical bovine mastitis cases from the West Littoral Region of Uruguay.
| MIC1 (μg/ml) | % Resistance | |||||
|---|---|---|---|---|---|---|
| Antimicrobial Agent | MIC502 | MIC903 | Range | Breakpoint | VETMIC | Agar disk diffusion test |
| Penicillin | 0.12 | 0.12 | ≤ 0.06–0.12 | ≥ 4 | 0.0 | 0.0 |
| Ampicillin | 0.25 | 0.25 | ≤ 0.12–0.25 | ≥ 8 | 0.0 | 0.0 |
| Cephalotin | ≤ 4 | ≤ 4 | ≤ 4 | ≥ 32 | 0.0 | 0.0 |
| Gentamicin | 8 | 16 | 4–16 | ≥ 16 | 85.0 | 85.0 |
| Erythromycin | ≤ 0.25 | ≤ 0.25 | ≤ 0.25–1 | ≥ 1 | 3.4 | 3.4 |
| Oxitetracycline | ≤ 0.25 | 0.5 | ≤ 0.25–2 | ≥ 8 | 0.0 | 0.0 5 |
| Trimethoprim/Sulfamethox. | 0.25 | 0.25 | ≤ 0.06–2 | ≥ 4 | 0.0 | ....4.... |
1 Minimum inhibitory concentration. 2 Lowest concentration inhibiting 50% of the isolated tested.
3 Lowest concentration inhibiting 90% of the isolated tested. 4 Test not performed.
5 Tetracycline disk were used to perform agar disks diffusion.
In vitro susceptibility of 9 strains of Streptococcus dysgalactiae obtained from clinical and sub-clinical bovine mastitis cases from the West Littoral Region of Uruguay.
| MIC1 (μg/ml) | % Resistance | |||||
|---|---|---|---|---|---|---|
| Antimicrobial Agent | MIC502 | MIC903 | Range | Breakpoint | VETMIC | Agar disk diffusion test |
| Penicillin | ≤ 0.06 | 0.12 | ≤ 0.06–0.12 | ≥ 4 | 0.0 | 0.0 |
| Ampicillin | ≤ 0.12 | 0.25 | ≤ 0.12–0.25 | ≥ 8 | 0.0 | 0.0 |
| Cephalotin | ≤ 4 | ≤ 4 | ≤ 4 | ≥ 32 | 0.0 | 0.0 |
| Gentamicin | 8 | 8 | 4–8 | ≥ 16 | 0.0 | 0.0 |
| Erythromycin | ≤ 0.25 | ≤ 0.25 | ≤ 0.25 | ≥ 1 | 0.0 | 0.0 |
| Oxitetracycline | 8 | > 64 | 4–> 64 | ≥ 8 | 89.0 | 89.0 5 |
| Trimethoprim/Sulfamethox. | 0.12 | 0.25 | ≤ 0.06–0 | ≥ 4 | 0.0 | ....4.... |
1 Minimum inhibitory concentration. 2 Lowest concentration inhibiting 50% of the isolated tested.
3 Lowest concentration inhibiting 90% of the isolated tested. 4 Test not performed.
5. Tetracycline disk were used to perform agar disks diffusion.
In vitro susceptibility of 33 strains of Streptococcus uberis obtained from clinical and sub-clinical bovine mastitis cases from the West Littoral Region of Uruguay.
| MIC1 (μg/ml) | % Resistance | |||||
|---|---|---|---|---|---|---|
| Antimicrobial Agent | MIC502 | MIC903 | Range | Breakpoint | VETMIC | Agar disk diffusion test |
| Penicillin | ≤ 0.06 | 0.12 | ≤ 0.06–0.12 | ≥ 4 | 0.0 | 0.0 |
| Ampicillin | ≤ 0.12 | 0.25 | ≤ 0.12–0.25 | ≥ 8 | 0.0 | 0.0 |
| Cephalotin | ≤ 4 | ≤ 4 | ≤ 4 | ≥ 32 | 0.0 | 0.0 |
| Gentamicin | 16 | > 16 | ≤ 1–> 16 | ≥ 16 | 88.0 | 83.0 5 |
| Erythromycin | ≤ 0.25 | ≤ 0.25 | ≤ 0.25 | ≥ 1 | 0.0 | 0.0 |
| Oxitetracycline | ≤ 0.25 | 0.5 | ≤ 0.25–64 | ≥ 8 | 0.0 | 0.0 6 |
| Trimethoprim/Sulfamethox. | 0.12 | 0.25 | ≤ 0.06–0.5 | ≥ 4 | 0.0 | ....4.... |
1 Minimum inhibitory concentration. 2 Lowest concentration inhibiting 50% of the isolated tested.
3 Lowest concentration inhibiting 90% of the isolated tested. 4 Test not performed.
5 No significant differences between methods. 6 Tetracycline disk were used to perform agar disks diffusion.
In vitro susceptibility of 43 strains of Enterococcus sp. obtained from clinical and sub-clinical bovine mastitis cases from the West Littoral Region of Uruguay.
| MIC1(μg/ml) | % Resistance | |||||
|---|---|---|---|---|---|---|
| Antimicrobial Agent | MIC502 | MIC903 | Range | Breakpoint | VETMIC | Agar disk diffusion test |
| Penicillin | 0.5 | 4 | 0.12–> 8 | ≥ 16 | 7.0 | 7.0 |
| Ampicillin | 0.5 | 4 | ≤ 0.12–16 | ≥ 16 | 2.3 | 2.3 |
| Gentamicin | ≤ 1 | 4 | ≤ 1–4 | ≥ 16 | 0.0 | 0.0 |
| Erythromycin | ≤ 0.5 | ≤ 0.5 | ≤ 0.5–4 | ≥ 8 | 4.6 | 4.6 |
| Oxitetracycline | 2 | 2 | ≤ 0.25–2 | ≥ 16 | 0.0 | 2.0 56 |
| Trimethoprim/Sulfamethox. | > 8 | > 8 | 1–> 8 | ≥ 4 | 97.7 | ....4.... |
1 Minimum inhibitory concentration. 2 Lowest concentration inhibiting 50% of the isolated tested.
3 Lowest concentration inhibiting 90% of the isolated tested. 4 Test not performed.
5No significant differences between methods. 6 Tetracycline disk were used to perform agar disks diffusion.